[144] Phreesia, Inc. SEC Filing

Rhea-AI Filing Summary

Phreesia, Inc. reported a Form 144 notice for the proposed sale of 45,147 common shares through Fidelity Brokerage Services with an aggregate market value of $1,445,601.82. The filing lists approximately 59,504,269 shares outstanding and an approximate sale date of 08/27/2025 on the NYSE. The securities were acquired through option exercise and restricted stock vesting between 01/11/2022 and 01/15/2024 totaling the reported lots. A prior sale by the same person, Evan Roberts, shows 1,892 shares sold on 07/17/2025 for $50,867.93. The filer certifies no undisclosed material information.

Positive

• Complete disclosure of acquisition dates, nature of acquisition, and broker details supports regulatory transparency
• Specific sale information including exact share counts, aggregate market value, and prior recent sale enhances investor visibility

Negative

• Insider selling activity: proposed sale of 45,147 shares and a prior sale of 1,892 shares may be viewed as insider liquidity (factually reported)

Insights

Securities Analyst

TL;DR: Routine insider sale notice disclosing planned sale of 45,147 shares valued at $1.45M; compliant disclosure but signals insider liquidity.

The Form 144 is a standard disclosure of a proposed sale by an insider or other person subject to Rule 144 aggregation requirements. It identifies the broker, proposed sale date, number of shares to be sold, and the acquisition history showing stock option exercise and restricted stock vesting. The filing includes a recent small sale of 1,892 shares generating $50,867.93, which demonstrates prior disposition activity. From a disclosure and compliance standpoint the filing is complete and timely as presented; it does not indicate undisclosed material developments in the issuer's business.

Corporate Governance Expert

TL;DR: Properly filed Form 144 with detailed acquisition and sale history; important for transparency but not materially adverse by itself.

The document provides the necessary attestations under Rule 144, including acquisition dates and nature of acquisition (option exercise and restricted stock vesting). The explicit representation that the seller does not possess undisclosed material information is standard and important. While insider selling can be considered when assessing insider confidence, this filing alone contains no operational or financial disclosures about the company and therefore has limited impact on corporate governance assessments beyond transparency confirmation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	45147	1445601.82	59504269	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/11/2022	Stock Option Exercise	Issuer			463	01/11/2022	Cash
Common	01/14/2023	Restricted Stock Vesting	Issuer			1524	01/14/2023	Compensation
Common	01/15/2023	Restricted Stock Vesting	Issuer			20521	01/15/2023	Compensation
Common	01/15/2024	Restricted Stock Vesting	Issuer			22639	01/15/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Evan Roberts 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	1892	50867.93

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Phreesia (PHR) disclose in this Form 144?

The Form 144 reports a proposed sale of 45,147 common shares through Fidelity with an aggregate market value of $1,445,601.82, and lists acquisition dates and methods.

When is the approximate sale date listed for the PHR shares?

The filing lists an approximate sale date of 08/27/2025 on the NYSE.

Who is the seller named in the filing?

The filing identifies Evan Roberts (address included in the form) as a person who sold shares and as the contact for the prior sale shown.

How many shares did the filer sell recently before this notice?

A prior sale on 07/17/2025 shows 1,892 shares sold for $50,867.93.

How were the reported shares acquired?

The listed shares were acquired via stock option exercise and restricted stock vesting between 01/11/2022 and 01/15/2024, with specific lot sizes provided in the filing.